Canada Life’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.84M | Sell |
53,890
-157
| -0.3% | -$24.1K | 0.02% | 550 |
|
|
2025
Q4 | $9.41M | Buy |
54,047
+7,005
| +15% | +$1.28M | 0.02% | 535 |
|
|
2025
Q3 | $6.66M | Buy |
47,042
+792
| +2% | +$97K | 0.01% | 705 |
|
|
2025
Q2 | $4.66M | Buy |
46,250
+3,792
| +9% | +$290K | 0.01% | 818 |
|
|
2025
Q1 | $3.25M | Buy |
42,458
+3,079
| +8% | +$236K | 0.01% | 979 |
|
|
2024
Q4 | $2.72M | Buy |
39,379
+1,568
| +4% | +$113K | ﹤0.01% | 1127 |
|
|
2024
Q3 | $2.77M | Sell |
37,811
-8,732
| -19% | -$644K | ﹤0.01% | 1155 |
|
|
2024
Q2 | $3.12M | Sell |
46,543
-3,685
| -7% | -$143K | 0.01% | 1064 |
|
|
2024
Q1 | $1.36M | Buy |
50,228
+30
| +0.1% | +$840 | ﹤0.01% | 1409 |
|
|
2023
Q4 | $1.55M | Buy |
50,198
+11,358
| +29% | +$295K | ﹤0.01% | 1359 |
|
|
2023
Q3 | $980K | Buy |
38,840
+9,690
| +33% | +$222K | ﹤0.01% | 1483 |
|
|
2023
Q2 | $619K | Buy |
29,150
+5,025
| +21% | +$95.3K | ﹤0.01% | 1631 |
|
|
2023
Q1 | $411K | Buy |
24,125
+17,297
| +253% | +$336K | ﹤0.01% | 1742 |
|
|
2022
Q4 | $137K | Buy |
6,828
+1,011
| +17% | +$19.5K | ﹤0.01% | 1931 |
|
|
2022
Q3 | $125K | Hold |
5,817
| – | – | ﹤0.01% | 1948 |
|
|
2022
Q2 | $115K | Hold |
5,817
| – | – | ﹤0.01% | 1896 |
|
|
2022
Q1 | $145K | Hold |
5,817
| – | – | ﹤0.01% | 1926 |
|
|
2021
Q4 | $158K | Hold |
5,817
| – | – | ﹤0.01% | 1916 |
|
|
2021
Q3 | $161K | Hold |
5,817
| – | – | ﹤0.01% | 1950 |
|
|
2021
Q2 | $165K | Sell |
5,817
-1,198
| -17% | -$35.6K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $237K | Hold |
7,015
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q4 | $233K | Hold |
7,015
| – | – | ﹤0.01% | 1932 |
|
|
2020
Q3 | $226K | Hold |
7,015
| – | – | ﹤0.01% | 1873 |
|
|
2020
Q2 | $192K | Buy |
7,015
+1,404
| +25% | +$33.3K | ﹤0.01% | 1913 |
|
|
2020
Q1 | $90K | Hold |
5,611
| – | – | ﹤0.01% | 2002 |
|
|
2019
Q4 | $133K | Buy |
+5,611
| New | +$114K | ﹤0.01% | 2016 |
|
|
2019
Q3 | – | Sell |
-9,005
| Closed | -$230K | – | 1682 |
|
|
2019
Q2 | $230K | Sell |
9,005
-3,037
| -25% | -$84.6K | ﹤0.01% | 1994 |
|
|
2019
Q1 | $349K | Buy |
12,042
+3,181
| +36% | +$82.4K | ﹤0.01% | 1734 |
|
|
2018
Q4 | $112K | Hold |
8,861
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q3 | $179K | Hold |
8,861
| – | – | ﹤0.01% | 2015 |
|
|
2018
Q2 | $210K | Sell |
8,861
-1,914
| -18% | -$49.3K | ﹤0.01% | 1967 |
|
|
2018
Q1 | $243K | Hold |
10,775
| – | – | ﹤0.01% | 1905 |
|
|
2017
Q4 | $335K | Buy |
10,775
+3,893
| +57% | +$115K | ﹤0.01% | 1837 |
|
|
2017
Q3 | $210K | Hold |
6,882
| – | – | ﹤0.01% | 1937 |
|
|
2017
Q2 | $118K | Hold |
6,882
| – | – | ﹤0.01% | 2066 |
|
|
2017
Q1 | $120K | Hold |
6,882
| – | – | ﹤0.01% | 2059 |
|
|
2016
Q4 | $91K | Hold |
6,882
| – | – | ﹤0.01% | 2146 |
|
|
2016
Q3 | $100K | Hold |
6,882
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q2 | $68K | Hold |
6,882
| – | – | ﹤0.01% | 2232 |
|
|
2016
Q1 | $87K | Hold |
6,882
| – | – | ﹤0.01% | 1880 |
|
|
2015
Q4 | $125K | Hold |
6,882
| – | – | ﹤0.01% | 1603 |
|
|
2015
Q3 | $128K | Hold |
6,882
| – | – | ﹤0.01% | 1525 |
|
|
2015
Q2 | $168K | Hold |
6,882
| – | – | ﹤0.01% | 1472 |
|
|
2015
Q1 | $143K | Hold |
6,882
| – | – | ﹤0.01% | 1545 |
|
|
2014
Q4 | $106K | Buy |
+6,882
| New | +$97.7K | ﹤0.01% | 1707 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Canada Life's INSM Position: Q1 2026 in Review
Canada Life reduced its Insmed (INSM) stake by 0.29% in Q1 2026, selling an estimated $24.1K and leaving 53,890 shares worth $8.84M. The position accounts for 0.02% of the portfolio, ranked #550.
Canada Life first reported a position in INSM in Q4 2014 and has held it in 45 quarters since. The position peaked at $9.41M in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Canada Life held 53,890 shares of Insmed worth $8.84M as of Q1 2026.
- Canada Life sold 157 Insmed shares in Q1 2026, an estimated $24.1K.
- Insmed made up 0.02% of Canada Life's portfolio in Q1 2026, its #550 holding.
- Canada Life first reported a position in Insmed in Q4 2014 and has held it in 45 quarters since.
- Canada Life's Insmed position peaked at $9.41M in Q4 2025.
- 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.